Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Novel therapeutic approaches for various forms of thrombocytopenia

Novel therapeutic approaches for various forms of thrombocytopenia

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

On the trail of a targeted therapy for blood cancer

On the trail of a targeted therapy for blood cancer

Researchers explore issues related to multiple myeloma treatment

Researchers explore issues related to multiple myeloma treatment

No blood needed thanks to non-invasive blood monitoring device

No blood needed thanks to non-invasive blood monitoring device

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Cytopia announces novel anti-cancer drug development collaboration

Cytopia announces novel anti-cancer drug development collaboration

Role of genetic components of dendritic cells could lead to more effective drugs

Role of genetic components of dendritic cells could lead to more effective drugs

Researchers study Rituximab's action on cancer stem cells

Researchers study Rituximab's action on cancer stem cells

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Proteolix's Carfilzomib granted orphan drug designation

Proteolix's Carfilzomib granted orphan drug designation

Thalidomide shows promise for treatment of recurrent ovarian cancer

Thalidomide shows promise for treatment of recurrent ovarian cancer

New cancer center at NewYork-Presbyterian/Weill Cornell

New cancer center at NewYork-Presbyterian/Weill Cornell

Experimental procedure induces tolerance to mismatched kidney transplants

Experimental procedure induces tolerance to mismatched kidney transplants

Stem cells make bone marrow cancer resistant to treatment

Stem cells make bone marrow cancer resistant to treatment

Salinispora tropica marine bacterium points to new ways to treat human diseases

Salinispora tropica marine bacterium points to new ways to treat human diseases

Novel anti-tumor compound

Novel anti-tumor compound

Bisphosphonates appear to reduce the risk of jaw degradation

Bisphosphonates appear to reduce the risk of jaw degradation